Search

Your search keyword '"Novo Nordisk A/S -- Reports"' showing total 133 results
Start Over Descriptor "Novo Nordisk A/S -- Reports" Topic business
133 results on '"Novo Nordisk A/S -- Reports"'

1. New study examines if GLP-1 drugs linked to greater suicidal thoughts

Subjects
Novo Nordisk A/S -- Reports, Suicidal behavior -- Complications and side effects -- Research, Drugs -- Research -- Complications and side effects, Pharmaceutical industry -- Reports -- Research -- Analysis, Business, News, opinion and commentary, World Health Organization -- Reports, Ozempic (Medication) -- Complications and side effects -- Research -- Reports
Abstract

A new observational study that analyzed a World Health Organization database that tracks suspected adverse drug reactions found that there was a greater rate of reports of suicidal thoughts associated [...]

Published
2024

2. Ozempic manufacturing costs could be 89c per month, study finds

Subjects
Novo Nordisk A/S -- Reports, Diabetes therapy -- Economic aspects -- Reports -- Research, Hypoglycemic agents -- Research, Manufacturing costs -- Reports -- Research -- Economic aspects, Pharmaceutical industry -- Reports -- Economic aspects -- Research, Business, News, opinion and commentary, Ozempic (Medication) -- Research -- Reports
Abstract

Novo Nordisk's (LLY) Ozempic could be manufactured for 89c to $4.73 for one month's supply, according to an investigation published in JAMA Network Open. The study asks what prices of [...]

Published
2024

3. CBO analyst comments on obesity drugs similar to October 2023 report

Subjects
Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Medical care, Cost of -- Reports, Obesity -- Reports, Drugs -- Reports, Weight loss -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) moved lower after Bloomberg reported comments today from Noelia Duchovny, a Congressional Budget Office analyst, at a U.S. National Academies workshop. [...]

Published
2024

4. Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

Subjects
Vertex Pharmaceuticals Inc. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Dapagliflozin -- Reports, Diabetes therapy -- Reports, Insulin glargine -- Reports, Type 1 diabetes -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-October 23, 2024-: Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers (C)1994-2024 M2 COMMUNICATIONS RDATE:22102024 DelveInsight's, 'Type 1 Diabetes Pipeline Insight 2024' report [...]

Published
2024

5. Q1 2024 Indutrade AB Earnings Call - Final

Subjects
Novo Nordisk A/S -- Reports, Trading companies -- Reports, Pharmaceutical industry -- Reports, Business
Abstract

Presentation OPERATOR: This call is being recorded. Your line is muted. Welcome to the Indutrade Q1 presentation for 2024. (Operator Instructions) Now, I will hand the conference over to CEO, [...]

Published
2024

6. Penn study finds taking semaglutide for weight management does not increase risk of depression or suicidal behavior in people without known major psychopathology

Subjects
United States. Food and Drug Administration -- Reports, Novo Nordisk A/S -- Reports, Suicidal behavior -- Research -- Risk factors, Medical research -- Psychological aspects -- Reports, Medicine, Experimental -- Psychological aspects -- Reports, Mental health -- Psychological aspects -- Reports -- Research, Depression, Mental -- Research -- Risk factors, Psychology, Pathological -- Psychological aspects -- Reports -- Research, Type 2 diabetes -- Research -- Risk factors, Weight loss -- Risk factors -- Research, Pharmaceutical industry -- Reports -- Psychological aspects -- Research, Business, Health, Health care industry, University of Pennsylvania. Perelman School of Medicine -- Reports
Abstract

2024 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- PHILADELPHIA- Taking the weight loss medication semaglutide did not increase [...]

Published
2024

7. Data from Copenhagen University Hospital Provide New Insights into Tongue Cancer (Feasibility of a Novel 3D Ultrasound Imaging Technique for Intraoperative Margin Assessment during Tongue Cancer Surgery)

Subjects
Novo Nordisk A/S -- Reports, Ultrasound imaging -- Reports -- Methods, Tongue cancer -- Reports -- Methods, Squamous cell carcinoma -- Reports -- Methods, Pharmaceutical industry -- Reports -- Methods, Surgery -- Reports -- Methods, Business, Health, Health care industry
Abstract

2024 AUG 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on tongue cancer is now available. According to news reporting out of [...]

Published
2024

8. Type 1 Diabetes Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)

Subjects
Vertex Pharmaceuticals Inc. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Dapagliflozin -- Reports, Diabetes therapy -- Reports, Insulin glargine -- Reports, Type 1 diabetes -- Reports, Drug approval -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-May 14, 2024-: Type 1 Diabetes Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated) (C)1994-2024 M2 COMMUNICATIONS RDATE:13052024 DelveInsight's, 'Type 1 Diabetes Pipeline [...]

Published
2024

9. Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk

Subjects
Genzyme Corp. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Business -- Research, Biotechnology industry -- Reports, Drugs -- Reports, Hemophilia -- Reports, Drug approval -- Reports, Blood coagulation factor VIII -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 1, 2024-: Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, (C)1994-2024 [...]

Published
2024

10. Human Insulin Drugs Market In Brazil 2023-2028: Market Analysis, Drivers, Restraints, Opportunities, and Threats - 17000 + Technavio Reports

Subjects
Merck & Company Inc. -- Reports, Becton, Dickinson and Co. -- Reports, Medtronic PLC -- Reports, Mannkind Corp. -- Reports, Novartis AG -- Reports, Biocon Ltd. -- Reports, Gulf Pharmaceutical Industries -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Sanofi S.A. -- Reports, Wockhardt Ltd. -- Reports, Diabetes therapy -- Reports, Medical test kit industry -- Reports, Medical equipment and supplies industry -- Reports, Insulin -- Reports, Automobile drivers -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 25, 2024 /PRNewswire/ -- Thehttps://c212.net/c/link/?t=0&l=en&o=4075736-1&h=405393281&u=http%3A%2F%2Fwww.technavio.com%2Freport%2Freport%2Fhuman-insulin-drugs-market-industry-in-brazil-analysis%3Futm_source%3Dprnewswire%26utm_medium%3Dpressrelease%26utm_campaign%3DLatest_t47_v2_wk04_2024_016_rep%26utm_content%3DIRTNTR72533&a=Human+Insulin+Drugs+Market+in+Brazil report has been added to Technavio's offering. The human insulin drugs market in Brazil is estimated to grow byUSD 181.76 million during [...]

Published
2024

11. Chronic Kidney Disease Competitive Landscape Report 2023 (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others

Subjects
Boehringer Ingelheim GmbH -- Reports, AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Business -- Research, Dapagliflozin -- Reports, Chronic kidney failure -- Reports, Erythropoietin, Recombinant -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-December 19, 2023-: Chronic Kidney Disease Competitive Landscape Report 2023 (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others. (C)1994-2023 M2 [...]

Published
2023

12. University of Southern Denmark Reports Findings in Science (Test-retest reliability of lower limb muscle strength, jump and sprint performance tests in elite female team handball players)

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports -- Research, Arts and entertainment industries, Business
Abstract

2024 APR 26 (VerticalNews) -- By a News Reporter-Staff News Editor at Entertainment Newsweekly -- New research on Science is the subject of a report. According to news originating from [...]

Published
2024

13. Pharma's Climate Plan: The industry is rarely mentioned among the chief planet polluters--and companies are intensifying their sustainability efforts to make sure it stays that way

Author

Pantuso, Phillip

Subjects
Novo Nordisk A/S -- Reports, Sustainable development -- Reports, Global temperature changes -- Reports, Sustainable living -- Reports, Pharmaceutical industry -- Reports, Business, Health care industry, McMaster University -- Reports
Abstract

* In August, the Intergovernmental Panel on Climate Change (IPCC), a body of scientists convened by the United Nations, issued a long-anticipated report. You probably heard about it: Based on [...]

Published
2021

14. Study shows semaglutide benefits heart failure patients

Author

Weiser, Patricia

Subjects
Novo Nordisk A/S -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Diabetes therapy -- Reports, Hypoglycemic agents -- Reports, Cardiac patients -- Reports, Weight reducing preparations -- Reports, Weight loss -- Reports, Pharmaceutical industry -- Reports, Heart failure -- Reports, Business, Health care industry, Ozempic (Medication) -- Reports, Wegovy (Medication) -- Reports
Abstract

STUDY AFTER STUDY HAS SHOWN that adopting a healthier lifestyle and losing weight can improve the outcomes for individuals with medical conditions. But can a weight loss drug produce the [...]

Published
2023

15. Global Monoclonal Antibodies Market Landscape Assessment 2023: Developments, Trends, Competitors and Products

Subjects
Merck KGaA -- Reports, Bristol-Myers Squibb Co. -- Reports, Novartis AG -- Reports, AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Biological products -- Reports, Business, News, opinion and commentary
Abstract

DUBLIN, June 23, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5794175/monoclonal-antibodies-competitive-landscape?utm_source=CI&utm_medium=PressRelease&utm_code=gx9wkr&utm_campaign=1858444+-+Global+Monoclonal+Antibodies+Market+Landscape+Assessment+2023%3a+Developments%2c+Trends%2c+Competitors+and+Products&utm_exec=joca220prd report has been added toResearchAndMarkets.com's offering. This report provides comprehensive insights about 180+ companies and 230+ drugs in the competitive landscape for [...]

Published
2023

16. Monoclonal Antibodies: Competitive Landscape Report, 2023 Featuring Insights of Novartis, Gmax Biopharm, Omeros Corp, and Merck Sharp & Dohme Among ~180 Other Players

Subjects
Merck KGaA -- Reports, Bristol-Myers Squibb Co. -- Reports, Novartis AG -- Reports, AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Biological products -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-June 7, 2023-: Monoclonal Antibodies: Competitive Landscape Report, 2023 Featuring Insights of Novartis, Gmax Biopharm, Omeros Corp, and Merck Sharp & Dohme Among ~180 Other Players (C)1994-2023 M2 COMMUNICATIONS [...]

Published
2023

17. Acquired Hemophilia A Pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired Hemophilia A treatment therapies, Analyzes DelveInsight

Subjects
Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Blood coagulation factors -- Reports, Hemophilia -- Reports, Blood coagulation factor VIII -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 27, 2023-: Acquired Hemophilia A Pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired Hemophilia A treatment therapies, Analyzes DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:26042023 (New York, [...]

Published
2023

18. Established cardiovascular disease in people living with overweight or obesity associated with more illness, death and medical costs than obesity alone, UK study in over 420,000 adults finds

Subjects
Novo Nordisk A/S -- Reports, Medical research -- Economic aspects -- Reports, Medicine, Experimental -- Economic aspects -- Reports, Obesity -- Economic aspects -- Reports, Medical economics -- Economic aspects -- Reports, Adults -- Economic aspects -- Reports, Cardiovascular diseases -- Economic aspects -- Reports, Pharmaceutical industry -- Reports -- Economic aspects, Business, Health, Health care industry
Abstract

2023 JUN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Adults at high cardiovascular risk and living with overweight or [...]

Published
2023

19. Hemophilia Pipeline Analysis: 80+ Companies are Working to Improve the Treatment Space | DelveInsight

Subjects
Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Business -- Research, Hemophilia -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 8, 2022-: Hemophilia Pipeline Analysis: 80+ Companies are Working to Improve the Treatment Space | DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:07112022 DelveInsight's, 'Hemophilia Pipeline Insight, 2022,' report provides comprehensive [...]

Published
2022

20. Human Growth Hormone Market Is Boosting Up Economy With 8.2% CAGR, Owing To Rising Awareness For Diagnosis And Treatment of Growth Hormone Disorders Till 2027 | Grand View Research, Inc

Subjects
Novo Nordisk A/S -- Reports, Medical research -- Economic aspects -- Reports, Medicine, Experimental -- Economic aspects -- Reports, Somatotropin -- Market size -- Reports -- Economic aspects, Pharmaceutical industry -- Reports -- Market size -- Economic aspects, Business, Business, international
Abstract

M2 PRESSWIRE-May 4, 2022-: Human Growth Hormone Market Is Boosting Up Economy With 8.2% CAGR, Owing To Rising Awareness For Diagnosis And Treatment of Growth Hormone Disorders Till 2027 | [...]

Published
2022

21. Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi - ResearchAndMarkets.com

Subjects
Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Insulin -- Reports, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

DUBLIN -- The 'Insulin Pens Market - Global Outlook & Forecast 2022-2027' report has been added to ResearchAndMarkets.com's offering. The insulin pens market is expected to grow at a CAGR [...]

Published
2022

22. Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi

Subjects
Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Insulin -- Reports, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

M2 PRESSWIRE-April 7, 2022-: Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi (C)1994-2022 M2 COMMUNICATIONS RDATE:07042022 The 'Insulin Pens [...]

Published
2022

23. Global Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease, By Syringe Size, By End User, By Regional Outlook and Forecast, 2021 - 2027

Subjects
Biocon Ltd. -- Reports, Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Dextrose -- Reports, Insulin glargine -- Reports, Hypodermic syringes -- Reports, Insulin -- Reports, Glucose -- Reports, Syringes -- Reports, Glucose metabolism -- Reports, Hypodermic needles -- Reports, Type 2 diabetes -- Reports, Pharmaceutical industry -- Industry forecasts, Banking, finance and accounting industries, Business, Humalog (Medication) -- Reports
Abstract

New York, April 04, Apr 04, 2022 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Insulin Syringes Market Size, Share & Industry Trends Analysis Report [...]

Published
2022

24. Novo Nordisk A/S to Discuss Updated 2020 Outlook Call - Final

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Semaglutide -- Reports, Business
Abstract

Presentation OPERATOR: Welcome to Novo Nordisk A/S Conference Call. (Operator Instructions) Today, I'm pleased to present President and CEO, Lars Fruergaard Jørgensen. Please go ahead with your meeting. LARS FRUERGAARD [...]

Published
2020

25. Copenhagen University Hospital Researchers Describe Findings in COVID-19 (Is time-restricted eating a robust eating regimen during periods of disruptions in daily life? A qualitative study of perspectives of people with overweight during ...)

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry
Abstract

2022 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators publish new report on COVID-19. According to news reporting [...]

Published
2022

26. Type 2 diabetes drug shows promise against obesity, study suggests. But it's expensive

Subjects
Novo Nordisk A/S -- Reports, Obesity -- Research -- Drug therapy, Diabetes therapy -- Reports -- Research, Hypoglycemic agents -- Research, Type 2 diabetes -- Research -- Drug therapy, Weight loss -- Drug therapy -- Research, Pharmaceutical industry -- Reports -- Research, Business, General interest, Business, regional
Abstract

Byline: Bethany Ao A new drug has been found to be so effective against obesity that it may help patients avoid consequences such as diabetes and hypertension, according to a [...]

Published
2021

27. Type 2 diabetes drug shows promise against obesity, study suggests. But it's expensive

Subjects
Novo Nordisk A/S -- Reports, Obesity -- Research -- Drug therapy, Diabetes therapy -- Reports -- Research, Hypoglycemic agents -- Research, Type 2 diabetes -- Research -- Drug therapy, Weight loss -- Drug therapy -- Research, Pharmaceutical industry -- Reports -- Research, Business, General interest, Business, regional
Abstract

Byline: Bethany Ao Feb. 12A new drug has been found to be so effective against obesity that it may help patients avoid consequences such as diabetes and hypertension, according to [...]

Published
2021

28. Novo Nordisk A S Files SEC Form SD, Specialized Disclosure Report: (May 31, 2022)

Subjects
United States. Securities and Exchange Commission -- Reports, Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2022 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2022

29. Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Reports, Biogen Inc. -- Reports, Amgen Inc. -- Reports, Hoffmann-La Roche AG -- Reports, Baxter International Inc. (Deerfield, Illinois) -- Reports, Johnson & Johnson -- Reports, AbbVie Inc. -- Reports, CSL Ltd. (Parkville, Victoria, Australia) -- Reports, Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Abbott Laboratories (Abbott Park, Illinois) -- Reports, Roche Holding AG -- Reports, Biological products industry -- Industry forecasts, Medical test kit industry -- Industry forecasts, Biotechnology industry -- Industry forecasts, Medical equipment and supplies industry -- Industry forecasts, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

DUBLIN -- The 'Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026' report has been added to ResearchAndMarkets.com's offering. The global protein therapeutics market exhibited moderate [...]

Published
2021

30. Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region

Subjects
Merck & Company Inc. -- Reports, Biogen Inc. -- Reports, Amgen Inc. -- Reports, Baxter International Inc. (Deerfield, Illinois) -- Reports, AbbVie Inc. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Abbott Laboratories (Abbott Park, Illinois) -- Reports, Hoffmann-La Roche AG -- Reports, Johnson & Johnson -- Reports, CSL Ltd. (Parkville, Victoria, Australia) -- Reports, Roche Holding AG -- Reports, Biological products industry -- Industry forecasts, Medical test kit industry -- Industry forecasts, Biotechnology industry -- Industry forecasts, Medical equipment and supplies industry -- Industry forecasts, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

M2 PRESSWIRE-October 18, 2021-: Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region (C)1994-2021 M2 COMMUNICATIONS RDATE:18102021 The 'Protein Therapeutics Market: Global [...]

Published
2021

31. Nonalcoholic Steatohepatitis Pipeline Insight Report 2021 - ResearchAndMarkets.com

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

DUBLIN -- The 'Nonalcoholic Steatohepatitis - Pipeline Insight, 2021' drug pipelines has been added to ResearchAndMarkets.com's offering. This 'Nonalcoholic Steatohepatitis - Pipeline Insight, 2021,' report provides comprehensive insights about 140+ [...]

Published
2021

32. Sickle Cell Disease Pipeline Landscape Expands With 50+ Drugs For Better Treatment Outlook

Subjects
United States. Food and Drug Administration -- Reports, Novartis AG -- Reports, Novo Nordisk A/S -- Reports, Sickle cell anemia -- Reports, Pharmaceutical industry -- Industry forecasts, Banking, finance and accounting industries, Business
Abstract

Los Angeles, USA, May 11, 2021 (GLOBE NEWSWIRE via COMTEX) -- Sickle Cell Disease Pipeline Landscape Expands With 50+ Drugs For Better Treatment Outlook. Approximately 40+ key companies are developing [...]

Published
2021

33. Diabetes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, ImCyse, Novo Nordisk, Enthera, ActoBio Th

Subjects
Novo Nordisk A/S -- Reports, Business -- Research, Diabetes therapy -- Reports, Biotechnology -- Reports, Type 2 diabetes -- Care and treatment, Pharmaceutical industry -- Reports, Insulin lispro -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 15, 2021-: Diabetes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, ImCyse, Novo Nordisk, Enthera, ActoBio Th [...]

Published
2021

34. Sickle Cell Disease Pipeline Analysis, unmet needs, opportunities, Key Players: Sanofi, Pfizer, Bristol Myers Squibb, Gilead Sciences, Novo Nordisk and Many More

Subjects
Gilead Sciences Inc. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Biological products industry -- Reports, Sickle cell anemia -- Diagnosis, Business -- Research, Medical research -- Reports, Medicine, Experimental -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 9, 2021-: Sickle Cell Disease Pipeline Analysis, unmet needs, opportunities, Key Players: Sanofi, Pfizer, Bristol Myers Squibb, Gilead Sciences, Novo Nordisk and Many More (C)1994-2021 M2 COMMUNICATIONS RDATE:09032021 [...]

Published
2021

35. Department of Otorhinolaryngology Researchers Report on Findings in COVID-19 (Valid and Reliable Assessment of Upper Respiratory Tract Specimen Collection Skills during the COVID-19 Pandemic)

Subjects
Novo Nordisk A/S -- Reports, Coronaviruses -- Analysis -- Reports -- Research, Pharmaceutical industry -- Analysis -- Reports -- Research, Business, Health, Health care industry
Abstract

2021 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New study results on coronavirus have been published. According to [...]

Published
2021

36. NF-kappa B Inhibitors Therapeutics Pipeline Analysis of 80+ Companies

Subjects
Novo Nordisk A/S -- Reports, Business -- Research, Pharmaceutical industry -- Reports, Banking, finance and accounting industries, Business
Abstract

Los Angeles, Dec 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- NF-kappa B Inhibitors Therapeutics Pipeline Analysis of 80+ Companies The Key Players involved in developing the NF-kappa B Inhibitors therapies [...]

Published
2020

38. Global Obesity Market Spotlight Report 2020 Featuring AstraZeneca, Boehringer Ingelheim, Gubra, Novo Nordisk

Subjects
AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Obesity -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

DUBLIN, Nov. 11, 2020 /PRNewswire/ -- The 'Market Spotlight: Obesity' report has been added toResearchAndMarkets.com's offering. This Market Spotlight report covers the Obesity market, comprising key marketed and pipeline drugs, [...]

Published
2020

39. Obesity Market Spotlight Report 2020: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-Specific Revenue Forecasts

Subjects
AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Obesity -- Reports, Banking, finance and accounting industries, Business
Abstract

Dublin, Oct 30, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Market Spotlight: Obesity' report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Obesity market, comprising key [...]

Published
2020

40. Global Continuous Glucose Monitoring Device Market (2020 to 2026) - by Component, End-user, Region, Industry Analysis and Forecast

Subjects
United States. Food and Drug Administration -- Reports, DexCom Inc. -- Reports, Novo Nordisk A/S -- Reports, Abbott Laboratories (Abbott Park, Illinois) -- Reports, Insulet Corp. -- Reports, Diabetes therapy -- Reports, Dextrose -- Reports, Medical test kit industry -- Industry forecasts, Sensors -- Reports, Medical equipment and supplies industry -- Industry forecasts, Patient monitoring equipment -- Reports, Glucose -- Reports, Blood sugar monitoring -- Reports, Type 2 diabetes -- Reports, Pharmaceutical industry -- Industry forecasts, Business, News, opinion and commentary
Abstract

DUBLIN, Sept. 2, 2020 /PRNewswire/ -- The 'Global Continuous Glucose Monitoring Device Market By Component, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026' report has been [...]

Published
2020

41. The Global Smart Insulin Pen Market is expected to grow from USD 23.09 Million in 2018 to USD 63.89 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.64%

Subjects
Hoffmann-La Roche AG -- Reports, Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Insulet Corp. -- Reports, Medical equipment industry -- Reports, Medical informatics -- Reports, Pharmaceutical industry -- Reports, Insulin -- Reports, Biological products industry -- Reports, Technology, Medical equipment, Legal fees, Vendor relations, Banking, finance and accounting industries, Business
Abstract

New York, May 11, May 11, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Smart Insulin Pen Market - Premium Insight, Competitive News Feed [...]

Published
2020

42. Global Biologics Market: Insight, Competition and Forecast (2020-2025) Featuring Eli Lilly, Sanofi, Pfizer, Roche, AbbVie, Amgen, Merck & Co, Novo Nordisk, BMS, and Johnson & Johnson - ResearchAndMarkets.com

Subjects
Johnson & Johnson -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Chronic diseases -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Medical economics, End users, Diseases, Business, Business, international
Abstract

DUBLIN -- The 'Global Biologics Market: Analysis By Product Type, Application Type, Product Pipeline, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)' report has [...]

Published
2020

43. Copenhagen University Hospital Researchers Add New Study Findings to Research in COVID-19 (Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants)

Subjects
Novo Nordisk A/S -- Reports, Biochemistry -- Genetic aspects -- Analysis -- Reports -- Research, Coronaviruses -- Analysis -- Reports -- Genetic aspects -- Research, Pharmaceutical industry -- Analysis -- Reports -- Research, Business, Health, Health care industry
Abstract

2021 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Current study results on coronavirus have been published. According to [...]

Published
2021

44. Study Data from Copenhagen University Hospital Provide New Insights into COVID-19 (Optimal Insertion Depth for Nasal Mid-Turbinate and Nasopharyngeal Swabs)

Subjects
Novo Nordisk A/S -- Reports, Coronaviruses -- Reports -- Research, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry
Abstract

2021 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators publish new report on coronavirus. According to news reporting [...]

Published
2021

45. Novo Nordisk A S Files SEC Form SD, Specialized Disclosure Report: (May 27, 2021)

Subjects
United States. Securities and Exchange Commission -- Reports, Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2021 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2021

46. Gilead and Novo Nordisk Report Expanded NASH Clinical Collaboration

Subjects
Gilead Sciences Inc. -- Reports, Novo Nordisk A/S -- Reports, Biological products industry -- Reports, Drug therapy, Combination -- Reports, Liver -- Reports, Liver diseases -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, Telecommunications industry
Abstract

Gilead Sciences and Novo Nordisk reported that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). According to a media release, the companies will conduct a Phase 2b [...]

Published
2021

47. Novo Nordisk Pars Awarded the Best Place To Work in Iran for 2019

Subjects
Novo Nordisk A/S -- Reports, Work environment -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

TEHRAN, Iran, Dec. 18, 2019 /PRNewswire/ -- Novo Nordisk Pars was recognized as the best place to work in Iran for 2019 according to the annual Workplace program driven by [...]

Published
2019

48. Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts

Subjects
AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Obesity -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, Belviq (Medication) -- Reports
Abstract

M2 PRESSWIRE-December 3, 2019-: Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts (C)1994-2019 M2 COMMUNICATIONS RDATE:03122019 The 'Market Spotlight: Obesity' report has been [...]

Published
2019

49. Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts - ResearchAndMarkets.com

Subjects
AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Obesity -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, Belviq (Medication) -- Reports
Abstract

DUBLIN -- The 'Market Spotlight: Obesity' report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Obesity market, comprising key marketed and pipeline drugs, clinical trials, recent [...]

Published
2019

50. Clinical Trials Market Advance & Cost Effective Technology 2019 to 2023 - By Industry Size, Share, Company Profiles, Impressive Growth, Demand, Latest Research & Future Profit

Subjects
Pfizer Inc. -- Reports, Charles River Laboratories Corp. -- Reports, Laboratory Corporation of America Holdings -- Reports, Eli Lilly and Co. -- Reports, ICON PLC -- Reports, Novo Nordisk A/S -- Reports, Health care industry -- International economic relations -- Reports, Medical research -- Reports, Agricultural industry -- International economic relations -- Reports, Pharmaceutical industry -- International economic relations -- Reports, Technology, End users, Hospitals, Health care industry, Business, Business, international
Abstract

M2 PRESSWIRE-November 4, 2019-: Clinical Trials Market Advance & Cost Effective Technology 2019 to 2023 - By Industry Size, Share, Company Profiles, Impressive Growth, Demand, Latest Research & Future Profit [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results